Fever: Pathological or physiological, injurious or beneficial?

Journal of Thermal Biology

Volumn 28, Issue 1, 2003, Pages 1-13

  Blatteis, Clark M ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANXIETY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CAREGIVER; FEVER; HEAT; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION; SIDE EFFECT; SURVIVAL;

EID: 0037255016     PISSN: 03064565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4565(02)00034-7     Document Type: Short Survey

References (105)

1. Aronoff, D., Neilson, E., 2001. Antipyretics: mechanisms of action and clinical use in fever suppression. Am. J. Med. 111, 304-315.
2. Atkins, E., 1982. Fever: it's history, cause and function. Yale J. Biol. Med. 55, 283-289.
3. Atkins, E., Bodel, P., 1979. Clinical fever: its history, manifestations and pathogenesis. Fed. Proc. 38, 57-63.
4. Banet, M., 1983. The biological function of fever: an alternative view. Funk. J. Biol. Med. 2, 211-218.
5. Banet, M., 1986. Fever in mammals: is it beneficial? Yale J. Biol. Med. 59, 117-124.
6. Barton, D., Schmitt, M.D., 1980. Fever phobia: misconceptions of parents about fevers. Am. J. Dis. Child. 134, 176-181.
7. Bender, B.S., Scarpace, P.J., 1997. Fever in the elderly. In: Mackowiak, P.A. (Ed.), Fever: Basic Mechanisms and Management, 2nd Edition. Lippincott-Raven, Philadelphia, pp. 363-373.
8. Bernheim, H.A., Kluger, M.J., 1976. Fever: effect of drug-induced antipyresis on survival. Science 193, 237-239.
9. Bernheim, H.A., Bodel, P.T., Askenase, P.W., Atkins, E., 1978. Effects of fever on host defense mechanisms after infection in the lizard Dipsosaurus dorsalis. Br. J. Exp. Pathol. 59, 76-84.
10. Beutler, B., 1999. The role of tumor necrosis factor in health and disease. J. Rheumatol. 26 (Suppl. 57), 16-21.
11. Blatteis, C.M., 1980. In: Lipton, J.M. (Ed.), Ontogenetic Development of Fever Mechanism. Raven, New York, pp. 177-188.
12. Blatteis, C.M., 1983. Research in perinatal thermoregulation: recent advances. J. Therm. Biol. 8, 191-194.
13. Blatteis, C.M., 1986. Fever: is it beneficial? Yale J. Biol. Med. 59, 107-116.
14. Blatteis, C.M., 1989. Thermal homeostasis during the neonatal period. Prog. Biometeorol. 7, 35-40.
15. Blatteis, C.M., Sehic, E., 1997. Prostaglandin E2: a putative fever mediator. In: Mackowiak, P.A. (Ed.), Fever: Basic Mechanisms and Management, 2nd Edition. Raven-Lippincott, New York, pp. 117-148.
16. Blatteis, C.M., Sehic, E., Li, S., 2000. Pyrogenic sensing and signaling: old views and new concepts. Clin. Infect. Dis. 31 (Suppl. 5), S168-S177.
17. Blumenthal, I., 1998. What parents think of fever. Fam. Pract. 15, 513-518.
18. Bonadio, W.A., Romine, K., Gyuro, J., 1990. Relationship of fever magnitude to rate of serious bacterial infections in neonates. J. Pediatr. 116, 733-735.
19. Bruunsgaard, H., Pedersen, M., Pedersen, B.K., 2001. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8, 131-136.
20. Burd, R., Dziedzic, T.S., Xu, Y., Caligiuri, M.A., Subjeck, J.R., Repasky, E.A., 1998. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J. Cell Physiol. 177, 137-147.
21. Cannon, J.G., 2000. Inflammatory cytokines in nonpathological states. News Physiol. Sci. 15, 298-303.
22. Cannon, J.G., Tompkins, R.G., Gelfand, J.A., Michie, H.R., Stanford, G.G., van der Meer, J.W., Endres, S., 1990. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161, 79-84.
23. Cooper, K.E., 1995. Fever and Antipyresis. Cambridge University Press, Cambridge, UK, 182 p.
24. Crocetti, M., Maghbeli, N., Serwint, J., 2001. Fever phobia revisited: have parental misconceptions about fever changed in 20 years? Pediatrics 107, 1241-1246.
25. Di, Y.-P., Repasky, E.A., Subjeck, J.R., 1997. Distribution of HSP70, protein kinase C, and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure. J. Cell Physiol. 172, 44-54.
26. Dinarello, C.A., 1996. Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147.
27. Dinarello, C.A., 1997a. Cytokines as endogenous pyrogens. In: Mackowiak, P.A. (Ed.), Fever: Basic Mechanisms and Management, 2nd Edition. Lippincott-Raven, Philadelphia, pp. 87-116.
28. Dinarello, C.A., 1997b. Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. J. Biol. Regul. Homeost. Agents 11, 91-103.
29. Dinarello, C.A., 1999. Cytokines as endogenous pyrogens. J. Infect. Dis. 179 (Suppl. 2), S294-S304.
30. Dinarello, C.A., 2000. Proinflammatory cytokines. Chest 41, 503-508.
31. Dinarello, C.A., Bunn, P.A., 1997. Fever. Semin. Oncol. 24, 288-298.
32. Dinarello, C.A., Pomerantz, B.J., 2001. Proinflammatory cytokines in heart disease. Blood Purif. 19, 314-321.
33. Dinarello, C.A., Shparber, M., Kent, E.F., Wolff, S.M., 1981. Production of leukocytic pyrogen from phagocytes of neonates. J. Infect. Dis. 144, 337-343.
34. Duff, G., 1986. Is fever beneficial to the host: A clinical perspective. Yale J. Biol. Med. 59, 125-130.
35. Ensor, J.E., Wiener, S.M., McCrea, K.A., Viscardi, R.M., Crawford, E.K., Hasday, J.D., 1994. Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-α expression. Am. J. Physiol. 266, C967-C974.
36. Evans, S.S., Schleider, D.M., Bowman, L., Francis, M.L., Kansas, G.S., Black, J.D., 1999. Dynamic association of L-selectin with the lymphocyte cytoskeletal matrix. J. Immunol. 162, 3615-3624.
37. Evans, S.S., Bain, M.D., Wang, W.-C., 2000. Fever range hyperthermia stimulates a4b7 integrin-dependent lymphocyte-endothelial adhesion. Int. J. Hyperthermia 16, 45-59.
38. Evans, S.S., Wang, W.-C., Bain, M.D., Burd, R., Ostberg, J.R., Repasky, E.A., 2001. Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood 97, 2727-2733.
39. Hanson, D.F., 1998. Fever, temperature, and the immune response. Ann. NY Acad. Sci. 813, 453-464.
40. Hasday, J.D., 1997. The influence of temperature on host defenses. In: Mackowiak, P.A. (Ed.), Fever: Basic Mechanisms and Management, 2nd Edition. Lippincott-Raven, Philadelphia, pp. 177-196.
41. Hasday, J.D., Garrison, A., 2000. Antipyretic therapy in patients with sepsis. Clin. Infect. Dis. 31, S234-S241.
42. Hasday, J.D., Bannerman, D., Sakarya, S., Cross, A.S., Singh, I.S., Howard, D., Drysdale, B.-E., Goldblum, S.E., 2001. Exposure to febrile temperature modifies endothelial cell response to tumor necrosis factor-α. J. Appl. Physiol. 90, 90-98.
43. Holtzclaw, B., 1995. The febrile response in critical care: state of the science. Heart Lung 21, 482-501.
44. Hughes, C.S., Repasky, E.A., Bankert, R.B., Johnson, R.J., Subjeck, J.R., 1987. Effects of hyperthermia on spectrin expression patterns of murine lymphocytes. Radiat. Res. 112, 116-123.
45. Iriki, M., 1988. Fever and fever syndrome - current problems. Jpn. J. Physiol. 38, 233-250.
46. IUPS Thermal Physiology Commission, 2001. Glossary of terms for thermal physiology. Jpn. J. Physiol. 51, 245-280.
47. Jansky, L.S., Vybiral, S., Pospisilova, D., Roth, J., Dorand, J., Zeisberger, E., Kaminkova, J., 1995. Production of systemic and hypothalamic cytokines during the early phase of endotoxin fever. Neuroendocrinology 62, 55-61.
48. Jiang, Q., DeTolla, L., van Rooijen, N., Singh, I.S., Fizgerald, B., Lipsky, M.M., Kane, A.S., Cross, A.S., Hasday, J.D., 1999a. Febrile-range temperature modifies early systemic tumor necrosis factor alpha expression in mice challenged with bacterial endotoxin. Infect. Immun. 67, 1539-1546.
49. Jiang, Q., DeTolla, L., Singh, I.S., Gatdula, L., Fitzgerald, B., van Rooijen, N., Cross, A.S., Hasday, J.D., 1999b. Exposure to febrile temperature upregulates expression of pyrogenic cytokines in endotoxin-challenged mice. Am. J. Physiol. 276, R1653-R1660.
50. Jiang, Q., Cross, A.S., Singh, I.S., Chen, T.T., Viscardi, R.M., Hasday, J.D., 2000. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect. Immun. 68, 1265-1270.
51. Kaven, I., Plaisance, M.D., Mackowiak, P.A., 2000. Antipyretic therapy. Arch. Intern. Med. 160, 449-456.
52. Klastersky, J., 1971. Etude experimentale et clinique des effets favorables et défavorables de la fièvre et de l' administration de corticoides au cours d' infections bactériennes. Acta Clin. Belg. 26 (Suppl. 6), 1-84.
53. Klein, N., Cunha, B., 1996. Treatment of fever. Infect. Dis. Clin. Amer. 10, 211-216.
54. Kluger, M.J., 1979. Fever. Its Biology, Evolution and Function. Princeton University Press, Princeton, NJ, 195p.
55. Kluger, M.J., 1986. Is fever beneficial. Yale J. Biol. Med. 59, 89-95.
56. Kluger, M.J., 1991. The adaptive value of fever. In: Mackowiak, P.A. (Ed.), Fever: Basic Mechanisms and Management. Raven Press, New York, pp. 105-124.
57. Kluger, M.J., 1997. The adaptive value of fever. In: Mackowiak, P.A. (Ed.), Fever: Basic Mechanisms and Management, 2nd Edition. Lippincott-Raven, Philadelphia, pp. 255-266.
58. Kluger, M.J., Rothenburg, B.A., 1979. Fever and reduced iron: their interaction as a host defense response to bacterial infection. Science 203, 374-376.
59. Kluger, M.J., Kozak, W., Conn, C.A., Leon, L.R., Soszynski, D., 1998. Role of fever in disease. Ann. NY Acad. Sci. 806, 224-233.
60. Kozak, W., 1993. Fever: a possible strategy for membrane homeostasis during infection. Perspect. Biol. Med. 37, 14-34.
61. Kozak, W., Kluger, M.J., Soszynski, D., Conn, C.A., Rudolph, K., Leon, L.R., Zheng, H., 1998. IL-6 and IL-1β in fever. Ann. NY Acad. Sci. 856, 33-49.
62. Kramer, M.S., Niamark, L., Leduc, D.G., 1985. Parental fever phobia and its correlates. Pediatrics 70, 1110-1113.
63. Kushner, I., Rzewnicki, D., 1999. Acute phase response. In: Gatlin, J.I., Snyderman, R. (Eds.), Inflammation: Basic Principles and Clinical Correlates, 3rd Edition. Lippincott Williams and Wilkins, Philadelphia, PA, pp. 317-329.
64. Mackowiak, P.A., 1991. Direct effects of physiologic variations in temperature on pathogenic microorganisms. In: Mackowiak, P.A. (Ed.), Fever: Basic Mechanisms and Management. Raven Press, New York, pp. 167-182.
65. Mackowiak, P.A., 1994. Fever: blessing or curse? A unifying hypothesis. Ann. Intern. Med. 120, 1037-1040.
66. Mackowiak, P.A. (Ed.), 1997a. Fever: Basic Mechanism and Management, 2nd Edition, Lippincott-Raven, Philadelphia, 506p.
67. Mackowiak, P.A., 1997b. Benefit versus risks of the febrile response. In: Mackowiak, P.A. (Ed.), Fever: Basic Mechanisms and Management, 2nd Edition. Lippincott-Raven, Philadelphia, pp. 279-286.
68. Mackowiak, P., 2000a. Physiological rationale for suppression of fever. Clin. Infect. Dis. 31 (Suppl 5), S185-S189.
69. Mackowiak, P.A., 2000b. Diagnostic implications and clinical consequences of antipyretic therapy. Clin. Infect. Dis. 31 (Suppl 5), S230-S233.
70. Mackowiak, P.A., Boulant, J., 1996. Fever's glass ceiling. Clin. Infect. Dis. 22, 525-536.
71. Mackowiak, P.A., Plaisance, K., 1998. Benefits and risks of antipyretic therapy. Ann. NY Acad. Sci. 856, 214-223.
72. Majno, G., Joris, I., 1996. Cells, tissues, and disease. Principles of general pathology. The Four Cardinal Signs of Inflammation, Blackwell Science, Cambridge, MA, pp. 365-383 (Chapter 10).
73. Marino, M.W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., Basu, S., Old, I., 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94, 8093-8098.
74. McCarthy, P.L., 1997. Fever in infants and children. In: Mackowiak, P.A. (Ed.), Fever: Basic Mechanisms and Management, 2nd Edition. Lippincott-Raven, Philadelphia, pp. 351-362.
75. Munford, R.S., Pugin, J., 2001. The crucial role of systemic responses in the innate (non-adaptive) host defense. J: Endotoxin Res. 7, 327-332.
76. Netea, M.G., Kullberg, B.J., van der Meer, J.W., 1999. Do only circulating pyrogenic cytokines act as mediators in the febrile response? A hypothesis. Eur. J. Clin. Invest. 29, 351-356.
77. Netea, M.G., Kullberg, B.J., van der Meer, J.W., 2000. Circulating cytokines as mediators of fever. Clin. Infect. Dis. 31 (Suppl. 5), S178-S184.
78. Ostberg, R.R., Repasky, E.A., 2000. Comparison of the effects of two different whole body hyperthermia protocols on the distribution of murine leukocyte population. Int. J. Hyperthermia 16, 29-43.
79. Ostberg, J.R., Patel, R., Repasky, E.A., 2000a. Regulation of immune activity by mild (fever-range) whole body hyperthermia: effects on epidermal Langerhans cells. Cell Stress Chaperones 5, 458-461.
80. Ostberg, J.R., Taylor, S.L., Baumann, H., Repasky, E.A., 2000b. Regulatory effects of fever-range whole-body hyperthermia on the LPS-induced acute inflammatory response. J. Leukoc. Biol. 68, 815-820.
81. Ostberg, J.R., Gellin, C., Patel, R., Repasky, E.A., 2001. Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigendependent cellular immune response. J. Immunol. 167, 2666-2670.
82. Pillay, V., Savage, N., Laburn, H., 1994. Circulating cytokine concentrations and cytokine production by monocytes from newborn babies and adults. Pflügers Arch. 428, 197-201.
83. Plaisance, K.I., Mackowiak, P.A., 2000. Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences. Arch. Intern. Med. 160, 449-456.
84. Roberts Jr., N.J., 1991a. Impact of temperature elevation on immunologic defenses. Rev. Infect. Dis. 13, 462-472.
85. Roberts Jr., N.J., 1991b. Immunological consequences of fever. In: Mackowiak, P.A. (Ed.), Fever: Basic Mechanisms and Management. Raven Press, New York, pp. 243-251.
86. Rodbard, D., Wachslicht-Rodbard, H., Rodbard, S., 1980. Temperature: a critical factor determining localization and natural history of infectious, metabolic and immunological diseases. Perspect. Biol. Med. 23, 439-474.
87. Roghmann, M.C., Warner, J., Mackowiak, P.A., 2001. The relationship between age and fever magnitude. Am. J. Med. Sci. 322, 68-70.
88. Roubenoff, R., Harris, T.B., Abad, L.W., Wilson, P.W., Dallal, G.E., Dinarello, C.A., 1998. Monocyte cytokine production in an elderly population: effect of age and inflammation. J. Gerontol. A Biol. Sci. Med. Sci. 53, M20-M26.
89. Singh, I.S., Viscardi, R.M., Kalvakolanu, I., Calderwood, S., Hasday, J.D., 2000. Inhibition of tumor necrosis factor-α transcription in macrophages exposed to febrile range temperature. J. Biol. Chem. 275, 9841-9848.
90. Singh, I.S., He, J.-R., Calderwood, S., Hasday, J.D., 2002. A high-affinity HSF-1 binding site in the 5′-untranslated region of the murine tumor necrosis factor-α gene is a transcriptional repressor. J. Biol. Chem. 277, 4981-4988.
91. Sirvent, J.-L., 2001. Prognostic value of cytokines in SIRS general medical patients. Cytokine 15, 232-236.
92. Steeber, D.A., Tang, M.L., Zhang, X.Q., Muller, W., Wagner, N., Tedder, T.F., 1998. Efficient lymphocyte migration across high endothelial venules of mouse Peyer's patches requires overlapping expression of L-selectin and b7 integrin. J. Immunol. 161, 6638-6647.
93. Styrt, B., Sugarman, B., 1990. Antipyresis and fever. Arch. Intern. Med. 150, 1589-1597.
94. Tracey, K., Cerami, A., 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Ann. Rev. Med. 45, 491-503.
95. Vane, J.R., Botting, R.M., 1998a. Mechanism of action of nonsteroidal antiinflammatory drugs. Am. J. Med. 104, 2S-8S; discussion 21S-22S.
96. Vane, J.R., Botting, R.M., 1998b. Antiinflammatory drugs and their mechanisms of action. Inflamm. Res. 47 (Suppl. 2), S78-S87.
97. Wagner-Jauregg, J., 1965. The treatment of dementia paralytica by malaria inoculation. In: Nobel Lectures: Physiology or Medicine, 1922-1941. Elsevier, New York, pp. 159-160.
98. Wang, W.-C., Goldman, L.M., Schleider, D.M., Appenheimer, M.M., Subjeck, J.R., Repasky, E.A., Evans, S.S., 1998. Fever-range hyperthermia enhances L-selectin-dependent adhesion of lymphocytes to vascular endothelium. J. Immunol. 160, 961-969.
99. Wang, X.-Y., Ostberg, J.R., Repasky, E.A., 1999. Effect of fever-like whole body hyperthermia on lymphocyte spectrin distribution, protein kinase C activity, and uropod formation. J. Immunol. 162, 3378-3387.
100. Ward, P.A., Lentsch, A.B., 1999. The acute inflammatory response and its regulation. Arch. Surg. 134, 666-669.
101. Weinberg, E.D., 1978. Iron and infection. Microbiol. Rev. 42, 45-66.
102. Whitrow, M., 1990. Wagner-Jauregg and fever therapy. Med. Hist. 34, 294-310.
103. Zitelli, B.J., 1991. Fever phobia and the adaptive value of fever. Indian J. Pediatr. 58, 275-278.
104. Zurovsky, Y., Mitchell, D., Laburn, H., 1987a. Pyrogens fail to produce fever in the leopard tortoise Geochelone pardalis. Comp. Biochem. Physiol. A 87, 467-469.
105. Zurovsky, Y., Brian, T., Laburn, H., Mitchell, D., 1987b. Pyrogens fail to produce fever in the snakes Psammophis phillipsii and Lamprophis fugilinosus. Comp. Biochem. Physiol. A 87, 911-914.